This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Strength Seen in Aeva Technologies (AEVA): Can Its 8.6% Jump Turn into More Strength?
by Zacks Equity Research
Aeva Technologies (AEVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AEVAPositive Net Change STRTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stem (STEM) Soars 8.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Stem (STEM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STEMPositive Net Change CTSHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Enovix Corporation (ENVX): Can Its 20.8% Jump Turn into More Strength?
by Zacks Equity Research
Enovix Corporation (ENVX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ENVXPositive Net Change BRTHYNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Grupo Televisa (TV)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
TVPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy TSMC (TSM) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TSMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Shoals Technologies Group (SHLS) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
SHLSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
OneSpaWorld (OSW) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
OSWPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Aurinia (AUPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AUPHPositive Net Change CORTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Core Scientific, Inc. (CORZ) Moves 33.0% Higher: Will This Strength Last?
by Zacks Equity Research
Core Scientific, Inc. (CORZ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
CORZPositive Net Change PJTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Flowserve (FLS) Surges 6.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Flowserve (FLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
FLSPositive Net Change IHICYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Aehr Test Systems (AEHR) Surges 9.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Aehr Test Systems (AEHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AEHRPositive Net Change CAMTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Ero Copper (ERO): Can Its 9.0% Jump Turn into More Strength?
by Zacks Equity Research
Ero Copper (ERO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ERONegative Net Change LEUNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Bumble (BMBL) Soars 25.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Bumble (BMBL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BMBLNegative Net Change ADPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Adaptive Biotechnologies (ADPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ADPTPositive Net Change FTREPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ivanhoe Electric (IE) Moves 8.7% Higher: Will This Strength Last?
by Zacks Equity Research
Ivanhoe Electric (IE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IEPositive Net Change AMRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
DLocal (DLO) Soars 8.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
DLocal (DLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
DLOPositive Net Change NYAXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cerence (CRNC) Moves 14.8% Higher: Will This Strength Last?
by Zacks Equity Research
Cerence (CRNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRNCPositive Net Change TLSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Camtek (CAMT) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
Camtek (CAMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CAMTPositive Net Change INTTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?
by Zacks Equity Research
Kamada (KMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KMDAPositive Net Change IMCRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?
by Zacks Equity Research
Ocular Therapeutix (OCUL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
OCULPositive Net Change TAKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Peakstone Realty Trust (PKST) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PKSTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
STMicroelectronics (STM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
STMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy ASML (ASML) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ASMLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in Krystal Biotech (KRYS): Can Its 4.2% Jump Turn into More Strength?
by Zacks Equity Research
Krystal Biotech (KRYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KRYSPositive Net Change CHRSPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Redwire Corporation (RDW) Surges 7.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Redwire Corporation (RDW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RDWPositive Net Change NOCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today